Home
Search 
BLAST
Manual
DownloadDetails of Virus RNA
Full list of proteins interacting with the 5'UTR - stem lops of this Strain
| Protein Name | Uniprot ID | Host Species | Pro Info | Detection Method | Infection Cell | Cell ID | Cell Originated Tissue | Infection Time | Interaction Score | Fold Change |
|---|---|---|---|---|---|---|---|---|---|---|
| Anaphase-promoting complex subunit 7 | Q9UJX3 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| ATP-dependent RNA helicase A | Q08211 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| ATP-dependent RNA helicase DDX1 | Q92499 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Cell proliferation-inducing gene 54 protein | Q29RF7 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| CHRAC subunit ACF1 | Q9NRL2 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| CLE7 homolog | Q9Y224 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| DNA topoisomerase 2-alpha | P11388 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| DNA-dependent protein kinase catalytic subunit | P78527 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| E3 ubiquitin-protein ligase UHRF1 | Q96T88 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| E3 ubiquitin/ISG15 ligase TRIM25 | Q14258 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Elongation factor 1-alpha 1 | P68104 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| General transcription factor 3C polypeptide 3 | Q9Y5Q9 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Glycogen phosphorylase | P06737 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| GTP-binding nuclear protein Ran | P62826 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heat shock 70 kDa protein 1A | P0DMV8 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoprotein A1 | P09651 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoprotein A3 | P51991 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoprotein D0 | Q14103 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoprotein H | P31943 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoprotein K | P61978 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoprotein Q | O60506 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoprotein R | O43390 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoprotein U | Q00839 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoproteins A2/B1 | P22626 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Importin-5 | O00410 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Interferon-inducible RNA-dependent protein kinase | P19525 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Interleukin enhancer-binding factor 2 | Q12905 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Interleukin enhancer-binding factor 3 | Q12906 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Nucleolin | P19338 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Nucleophosmin | P06748 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Poly [ADP-ribose] polymerase 1 | P09874 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Probable ATP-dependent RNA helicase DDX5 | P17844 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Ras GTPase-activating-like protein IQGAP1 | P46940 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Selenocysteine-specific elongation factor | P57772 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Splicing factor | P23246 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Splicing factor U2AF 35 kDa subunit | Q01081 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Sucrose nonfermenting protein 2 homolog | O60264 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Transcription activator BRG1 | P51532 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Transcription intermediary factor 1-beta | Q13263 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| X-ray repair cross-complementing protein 5 | P13010 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| X-ray repair cross-complementing protein 6 | P12956 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Y-box-binding protein 1 | P67809 | Homo sapiens | Pro Info | Nano-liquid chromatographytandem mass spectrometry (nanoLC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
Functional Go Enrichment analysis of those proteins interacting with the 5'UTR - stem lops of this Strain
| GO Term | GO Category | GO ID | Adjusted P-value | Odds Ratio | Combined Score |
|---|---|---|---|---|---|
| RNA Binding | Molecular Function |
GO:0003723
|
1.06E-26 | 43.11298042 | 2792.032185 |
| DNA Binding | Molecular Function |
GO:0003677
|
2.54E-11 | 15.69085645 | 449.7135683 |
| Telomeric DNA Binding | Molecular Function |
GO:0042162
|
3.43E-07 | 96.18725869 | 1802.723814 |
| mRNA Binding | Molecular Function |
GO:0003729
|
3.91E-06 | 16.90339201 | 270.8105039 |
| Double-Stranded RNA Binding | Molecular Function |
GO:0003725
|
6.82E-06 | 44.81531532 | 683.0503648 |
| pre-mRNA Binding | Molecular Function |
GO:0036002
|
1.05E-05 | 80.69635628 | 1180.679419 |
| Promoter-Specific Chromatin Binding | Molecular Function |
GO:1990841
|
3.08E-05 | 55.1800554 | 730.7061555 |
| Regulatory RNA Binding | Molecular Function |
GO:0061980
|
3.08E-05 | 55.1800554 | 730.7061555 |
| Single-Stranded RNA Binding | Molecular Function |
GO:0003727
|
3.08E-05 | 53.76248313 | 706.766736 |
| miRNA Binding | Molecular Function |
GO:0035198
|
0.000430116 | 58.9704142 | 613.5692979 |
| RNA Polymerase II Complex Binding | Molecular Function |
GO:0000993
|
0.000479607 | 54.75274725 | 558.5040283 |
| mRNA 3'-UTR Binding | Molecular Function |
GO:0003730
|
0.000491147 | 23.49970432 | 236.3668099 |
| RNA Polymerase Core Enzyme Binding | Molecular Function |
GO:0043175
|
0.000491147 | 51.0974359 | 511.4672259 |
| Purine Ribonucleoside Triphosphate Binding | Molecular Function |
GO:0035639
|
0.000550545 | 8.3108742 | 81.62418815 |
| Basal RNA Polymerase II Transcription Machinery Binding | Molecular Function |
GO:0001099
|
0.000554606 | 46.44522145 | 452.6100643 |
| RNA Polymerase II-specific DNA-binding Transcription Factor Binding | Molecular Function |
GO:0061629
|
0.000986424 | 11.95915647 | 108.8840844 |
| Double-Stranded Telomeric DNA Binding | Molecular Function |
GO:0003691
|
0.000998848 | 166.2666667 | 1501.640997 |
| G-rich Strand Telomeric DNA Binding | Molecular Function |
GO:0098505
|
0.001090146 | 142.5071429 | 1251.431951 |
| Tat Protein Binding | Molecular Function |
GO:0030957
|
0.001090146 | 142.5071429 | 1251.431951 |
| U3 snoRNA Binding | Molecular Function |
GO:0034511
|
0.001090146 | 142.5071429 | 1251.431951 |
| Nucleus | Cellular Component |
GO:0005634
|
3.22E-16 | 20.90361716 | 834.207452 |
| Intracellular Membrane-Bounded Organelle | Cellular Component |
GO:0043231
|
2.14E-14 | 17.30180969 | 605.8234837 |
| Nuclear Lumen | Cellular Component |
GO:0031981
|
1.21E-13 | 18.89370079 | 621.1639416 |
| Intracellular Non-Membrane-Bounded Organelle | Cellular Component |
GO:0043232
|
7.22E-13 | 14.53230174 | 447.6564897 |
| Nucleolus | Cellular Component |
GO:0005730
|
1.84E-11 | 15.65196128 | 428.0161551 |
| Chromosome | Cellular Component |
GO:0005694
|
1.31E-05 | 20.88607595 | 285.8233884 |
| Ficolin-1-Rich Granule Lumen | Cellular Component |
GO:1904813
|
5.67E-05 | 22.72102611 | 274.1678423 |
| Cytoplasmic Stress Granule | Cellular Component |
GO:0010494
|
0.000166565 | 29.07309942 | 315.5824048 |
| Ficolin-1-Rich Granule | Cellular Component |
GO:0101002
|
0.000308859 | 14.93205496 | 151.1050644 |
| Cytoplasmic Vesicle Lumen | Cellular Component |
GO:0060205
|
0.00067676 | 18.82124229 | 173.7147136 |
| Heterochromatin | Cellular Component |
GO:0000792
|
0.000930438 | 33.29765886 | 293.5543602 |
| Secretory Granule Lumen | Cellular Component |
GO:0034774
|
0.00288921 | 8.536977492 | 64.84664312 |
| Pericentric Heterochromatin | Cellular Component |
GO:0005721
|
0.004678555 | 52.47105263 | 369.0773539 |
| Nuclear Chromosome | Cellular Component |
GO:0000228
|
0.005136102 | 16.61036789 | 114.0552567 |
| Actin Cytoskeleton | Cellular Component |
GO:0015629
|
0.022148355 | 6.398891967 | 34.14479694 |
| Ribosome | Cellular Component |
GO:0005840
|
0.031412945 | 16.86355932 | 83.00333263 |
| Focal Adhesion | Cellular Component |
GO:0005925
|
0.034358479 | 5.379964271 | 25.55335816 |
| Cell-Substrate Junction | Cellular Component |
GO:0030055
|
0.034358479 | 5.267734554 | 24.65091956 |
| Spindle | Cellular Component |
GO:0005819
|
0.034358479 | 7.339650687 | 34.02722819 |
| Small-Subunit Processome | Cellular Component |
GO:0032040
|
0.034358479 | 14.00492958 | 64.08684545 |
| mRNA Splicing, Via Spliceosome | Biological Process |
GO:0000398
|
1.75E-13 | 44.73702543 | 1603.840561 |
| mRNA Processing | Biological Process |
GO:0006397
|
1.69E-10 | 34.53122517 | 976.683946 |
| RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile | Biological Process |
GO:0000377
|
6.75E-10 | 36.375 | 963.8168654 |
| CRD-mediated mRNA Stabilization | Biological Process |
GO:0070934
|
1.28E-09 | 539.2702703 | 13780.65678 |
| Regulation Of Translation | Biological Process |
GO:0006417
|
1.28E-09 | 32.17122396 | 815.4636939 |
| Negative Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay | Biological Process |
GO:1900152
|
1.58E-09 | 449.3693694 | 11211.6132 |
| Positive Regulation Of Cytoplasmic Translation | Biological Process |
GO:2000767
|
5.86E-09 | 299.5345345 | 7035.443024 |
| RNA Processing | Biological Process |
GO:0006396
|
1.03E-08 | 31.00940439 | 706.6451638 |
| DNA Metabolic Process | Biological Process |
GO:0006259
|
2.32E-08 | 22.12230216 | 483.5599918 |
| Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay | Biological Process |
GO:1900151
|
6.80E-08 | 149.6996997 | 3095.776748 |
| Regulation Of Cytoplasmic Translation | Biological Process |
GO:2000765
|
7.79E-08 | 141.8136558 | 2899.782475 |
| Positive Regulation Of DNA-templated Transcription | Biological Process |
GO:0045893
|
8.72E-08 | 9.394269952 | 190.2170633 |
| Positive Regulation Of Translation | Biological Process |
GO:0045727
|
1.27E-07 | 39.32079208 | 778.2189389 |
| DNA Repair | Biological Process |
GO:0006281
|
3.52E-07 | 19.02901354 | 355.84718 |
| Negative Regulation Of mRNA Catabolic Process | Biological Process |
GO:1902373
|
9.30E-07 | 74.78228228 | 1316.493282 |
| mRNA Metabolic Process | Biological Process |
GO:0016071
|
9.30E-07 | 41.93881857 | 737.8696973 |
| mRNA Stabilization | Biological Process |
GO:0048255
|
3.26E-06 | 56.05292793 | 912.5504428 |
| Negative Regulation Of DNA-templated Transcription | Biological Process |
GO:0045892
|
3.59E-06 | 8.392326564 | 135.3314895 |
| RNA Metabolic Process | Biological Process |
GO:0016070
|
3.90E-06 | 31.51269841 | 503.8840625 |
| Protein Localization To Cytoplasmic Stress Granule | Biological Process |
GO:1903608
|
9.75E-06 | 383.7307692 | 5763.945414 |
Functional KEGG Enrichment analysis of those proteins interacting with the 5'UTR - stem lops of this Strain
| Pathways | Category | Adjusted P-value | Odds Ratio | Combined Score |
|---|---|---|---|---|
| Spliceosome | KEGG Pathway | 1.26E-06 | 27.71328671 | 484.9854853 |
| Non-homologous end-joining | KEGG Pathway | 6.07E-05 | 153.4461538 | 1983.892119 |
| Necroptosis | KEGG Pathway | 0.075162958 | 9.764299803 | 52.74193823 |
| Legionellosis | KEGG Pathway | 0.079831059 | 18.09363636 | 91.43748115 |
| NF-kappa B signaling pathway | KEGG Pathway | 0.201426246 | 9.733333333 | 38.00785959 |
| Cell cycle | KEGG Pathway | 0.232795144 | 8.129508197 | 29.08624186 |
| Measles | KEGG Pathway | 0.241428923 | 7.233941606 | 24.36584523 |
| Amyotrophic lateral sclerosis | KEGG Pathway | 0.241428923 | 4.175793735 | 13.36728145 |
| Protein processing in endoplasmic reticulum | KEGG Pathway | 0.241428923 | 5.854733728 | 17.53113489 |
| Influenza A | KEGG Pathway | 0.241428923 | 5.82 | 17.36664691 |
| RNA transport | KEGG Pathway | 0.241428923 | 5.373369565 | 15.28857185 |
| Base excision repair | KEGG Pathway | 0.241428923 | 15.1875 | 41.03625328 |
| Viral carcinogenesis | KEGG Pathway | 0.241428923 | 4.914676617 | 13.23014939 |
| Proteoglycans in cancer | KEGG Pathway | 0.241428923 | 4.865763547 | 13.01546176 |
| Starch and sucrose metabolism | KEGG Pathway | 0.241428923 | 13.88362369 | 36.34745526 |
| Human T-cell leukemia virus 1 infection | KEGG Pathway | 0.241428923 | 4.548617512 | 11.64725571 |
| RIG-I-like receptor signaling pathway | KEGG Pathway | 0.378757181 | 7.030399434 | 13.97182574 |
| Adherens junction | KEGG Pathway | 0.378757181 | 6.929616725 | 13.68019618 |
| Leishmaniasis | KEGG Pathway | 0.378757181 | 6.380616175 | 12.11712668 |
| Antigen processing and presentation | KEGG Pathway | 0.378757181 | 6.297434273 | 11.88420746 |
Virus RNA Sequence Information
|
>U43141.1 Human immunodeficiency virus type 1 complete genome
AAGCTTGCCTTGAGTGCTTCAAGTAGTGTGTGCCCGTCTGTTGTGTGACTCTGGTAGCTAGAGATCCCTC
AGATCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGTGGCGCCCGAACAGGGACTTGAAAGCGAAAGTAGA
ACCAGAGGAGATCTCTCGACGCAGGACTCGGCTTGCTGAAGCGCGCACGGCAAGAGGCGAGGGGCGGCGA
CTGGTGAGTACGCCAAAATTTTGACTAGCGGAGGCTAGAAGGAGAGAGATGGGTGCGAGAGCGTCAGTAT
TAAGCGGGGGAGAATTAGACAAATGGGAAAAAATTCGGTTAAGGCCAGGGGGAAAGAAAAAATATCAATT
AAAACATATAGTATGGGCAAGCAGGGAGCTAGAACGATTCGCAGTTAATCCTGGCCTGTTAGAAACATCA
GAAGGCTGTAGACAGATAATGGGACAGCTACAACCGTCCCTTCAGACAGGATCAGAAGAACTTAGATCAT
TATATAATACAGTAGCAACCCTCTATTGTGTGCATCAAAAGATAGAGGTAAAAGACACCAAGGAAGCTTT
AGACAAGGTAGAGGAAGAGCAAAACAACAGTAAGAAAAAGGCACAGCAAGAAGCAGCTGACGCAGGAAAC
AGAAACCAGGTCAGCCAAAATTACCCTATAGTGCAAAACCTACAGGGACAAATGGTACATCAGGCCATAT
CACCTAGAACTTTAAATGCATGGGTAAAAGTAGTGGAAGAGAAGGCTTTCAGCCCAGAAGTAATACCCAT
GTTTTCAGCATTATCAGAAGGAGCCACCCCACAAGATTTAAACACCATGCTAAACACAGTGGGGGGACAT
CAAGCAGCCATGCAAATGTTAAAAGAAACCATCAATGAGGAAGCTGCAGAATGGGATAGATTGCACCCAG
TGCATGCAGGGCCTATTGCACCAGGCCAGATGAGAGAACCAAGGGGAAGTGACATAGCAGGAACTACTAG
TACCCTTCAGGAACAAATAGGATGGATGACAAATAATCCACCTATCCCAGTAGGAGAAATATATAAGAGA
TGGATAATCCTGGGATTAAATAAAATAGTAAGAATGTATAGCCCTACCAGCATTCTGGATATAAAACAAG
GACCAAAAGAACCCTTTAGAGATTATGTAGACCGGTTCTATAAAACCCTAAGAGCCGAGCAAGCTACACA
GGAAGTAAAAAATTGGATGACAGAAACCTTGTTGGTCCAAAATGCGAATCCAGATTGTAAGACTATTTTA
AAAGCATTAGGACCAGCAGCTACACTAGAAGAAATGATGACAGCATGTCAGGGAGTGGGGGGACCCGGCC
ATAAAGCAAGAGTTTTGGCTGAAGCAATGAGCCAAGTAACAGGTTCAGCTGCCATAATGATGCAGAGAGG
CAATTTTAGGAACCAAAGAAAGACTGTTAAGTGTTTCAATTGTGGCAAAGAAGGGCACATAGCCAGAAAT
TGCAGGGCCCCTAGGAAAAAGGGCTGTTGGAAATGTGGAAAGGAAGGACATCAAATGAAGGATTGCACAG
AAAGACAGGCTAATTTTTTAGGGAAGATCTGGCCTTCCCACAAGGGGAGGCCAGGAAATTTTCTTCAGAG
CAGACCAGAGCCAACAGCCCCACCAGAAGAGAGCTTCAGGTTTGGGGAAGCAACAGCTCCCTCTCAGAAG
CAGGAGCCGATAGACAAGGAACTGTATCCCTTAGCCTCCCTCAAATCACTCTTTGGCAGCGACCCCTCGT
CACAATAAAGATAGGGGGGCAACTAAAGGAAGCTCTATTAGATACAGGAGCAGATGATACAGTAGTAGAA
GAAATGAGTTTGCCAGGAAGATGGAAACCAAAAATGATAGGAGGAATTGGAGGTTTTATCAAAGTAAGAC
AGTATGATCAGATACTCGTAGAAATCTGTGGACATAAAGCTATAGGTACAGTATTAGTAGGACCTACACC
TGTCAACATAATTGGAAGAAATCTGTTGACTCAGATTGGTTGCACTTTAAATTTTCCCATTAGTCCTATT
GAAACTGTACCAGTAAAATTAAAGCCAGGAATGGATGGCCCAAAAGTTAAACAATGGCCATTGACAGAAG
AAAAAATAAAAGCATTAATAGAAATTTGTACAGAAATGGAAAAGGAAGGGAAAATTTCAAAAATTGGGCC
TGAAAATCCATACAATACTCCAGTATTTGCCATAAAGAAAAAGGACAGTACTAAATGGAGAAAATTAGTA
GATTTCAGAGAACTTAATAAAAGAACTCAAGATTTCTGGGAAGTTCAATTAGGAATACCACATCCCGCAG
GGTTAAAAAAGAAAAAATCAGTAACAGTCCTGGATGTGGGTGATGCATATTTTTCAGTTCCCCTAGATAA
AGACTTCAGAAAATATACTGCATTTACCATACCTAGTATAAACAATGAGACACCAGGGATTAGATATCAG
TACAATGTGCTTCCACAGGGATGGAAAGGATCACCAGCAATATTCCAAAGTAGCATGACAAAAATCTTAG
AGCCTTTTAGAAAACAAAATCCAGACATAGTTATCTATCAATACATGGATGATTTGTATGTAGGATCTGA
CTTAGAAATAGAGCAGCATAGAACAAAAATAGAGGAACTGAGACAGCATCTGTTGAAGTGGGGATTTACC
ACACCAGACAAAAAACATCAGAAAGAACCTCCATTCCTTTGGATGGGTTATGAACTCCATCCTGATAAAT
GGACAGTACAGCCTATAGTGCTGCCAGAAAAAGACAGCTGGACTGTCAATGACATACAGAAGTTAGTGGG
AAAATTGAATTGGGCAAGTCAGATTTATGCAGGGATTAAAGTAAAGCAATTATGTAAGCTACTTAGGGGA
CCCAAAGCACTAACAGAAGTAATACCACTAACAAAAGAAGCAGAGCTAGAACTAGCAGAAAACAGGGAGA
TTCTAAAAGAACCAGTACATGGAGTGTATTGTGACCCATCAAAAGACTTAGTAGCAGAAATACAGAAGCA
GGGGGAAGGCCAATGGACATATCAAATTTATCAAGAACCATTTAAGAATCTGAAAACAGGAAAGTATGCA
AGAATGAGGGGTGCCCACACTAATGATATAAAACAGTTAACAGAGGCAGTGCAAAAAATAGCCACAGAAG
GCATAGTAATATGGGGAAAGACTCCTAAATTTAGACTACCCATACAAAAGGAAACATGGGAAGCATGGTG
GACGGAGTATTGGCAAGCCACCTGGATTCCTGAGTGGGAGTTTGTCAATACCCCTCCCTTAGTGAAATTA
TGGTACCAGTTAGAGAAAGAACCCATAGTAGGAGCAGAAACTTTCTATGTAGATGGGGCAGCTAATAGGG
AGACTAAATTAGGAAAAGCAGGATATGTTACTGACAGGGGAAGACAAAAAGTTGTCTCCCTAAATGACAC
AACAAATCAGAAGACTGAGTTACAAGCAATTCATCTAGCTTTGCAGGATTCGGGACTAGAAGTAAACATA
GTAACAGACTCACAATATGCATTAGGAATCATTCAAGCACAACCAGATAAAAGTGAATCAGAGTTAGTCA
GTCAAATAATAGAGCAGTTAATAAAAAAGGAAAAGGTCTACCTGGCATGGGTACCAGCACACAAAGGAAT
TGGAGGAAATGAACAAGTAGATAAATTAGTCAGTGCTGGAATCAGAAAAGTACTATTTTTAGATGGAATA
GATAAGGCCCAAGAAGACCATGAGAAATATCACAGTAATTGGAGAGCAATGGCTAATGATTTTAACCTGC
CACCTGTAGTAGCAAAAGAAATAGTAGCCAGCTGTGATAAATGTCAGCTAAAAGGAGAAGCCATGCATGG
ACAAGTAGACTGTAGTCCAGGAATATGGCAACTAGATTGTACACATTTAGAAGGAAAAATTATCCTGGTA
GCAGTTCATGTAGCTAGTGGATATATAGAAGCAGAAGTCATTCCAGTAGAGACAGGGCAGGAAACAGCAT
ATTTTCTCTTAAAATTAGCAGGAAGATGGCCAGTAAAAACAGTACATACAGACAATGGCCCTAATTTCAC
CAGTACTACGGTTAAGGCCGCCTGTTGGTGGGCAGGGATCAAGCAGGAATTTGGCATTCCCTACAATCCC
CAAAGTCAAGGGGTAGTAGAATCTATGAATAAAGAGTTAAAGAAAATTATAGGACAGGTAAGAGATCAGG
CTGAACATCTTAAGACAGCAGTACAAATGGCAGTATTCATCCACAATTTTAAAAGAAAAGGGGGGATTGG
GGGGTACAGTGCAGGGGAAAGAATAGTAGACATAATAGCAACAGACATACAAACTAAAGAATTACAAAAA
CAAATTACAAAAATTCAAAATTTTCGGGTTTATTACAGGGACAGCAGAGAACCATTTTGGAAAGGACCAG
CAAAGCTTCTCTGGAAAGGTGAAGGGGCAGTAGTAATACAAGATAATAGTGACATAAAAGTAGTGCCAAG
AAGAAAAGCAAAGATCATTAGGGATTATGGAAAACAGATGGGCAGTGATGATTGTGTGGCAAGTAGACAG
GATGAGGATTAGAACATGGAACAGTTTAGTAAAACACCATATATATTGTTCACGGAAAGCTAAGAACTGG
GTTTATAGACATCACTATGAAAGCACTAATCCAAGAGTAAGTTCAGAAGTACACATCCCACTAGGGGAAG
CTAAATTGGTAATAACAACATATTGGGGTCTGCATACAGGAGAAAGAGACTGGCATTTGGGCCAGGGAGC
CTCCATAGAATGGAGGAAAAGGAGATATAGCACACAAGTAGACCCTAACCTAGCAGACCAACTAATTCAC
CTGTATTATTTTGATTGTTTTTCAGAATCTGCTATAAGAAATGCCATATTAGGACGTATAGTTAGTCCTA
GGTGTGAATATCAAGCAGGACATAGCAAGGTAGGATCTCTACAATACTTGGCACTAGCAGCATTAACAAC
ACCAAAAAAGATAAAGCCACCTTTGCCTATTGTTACAAAACTGACAGAAGATAGATGGAACAAGCCCCAG
AAGACCAAGGGCCACAGAGGGAGCCATACAATGCATGGACACTAGAGCTTTTAGAGGAGCTTAAGAGTGA
AGCTGTTAGACATTTTCCCAGGATATGGCTACATAGCTTAGGACAATATATCTATGAAACTTATGGGGAT
ACTTGGGCAGGAGTAGAAGCCATAATAAGAATACTGCAACAACTGCTGTTTATTCATTTCAGAATTGGGT
GTCGCCATAGCAGAATAGGCATTACTCCACAGAGGAGAGCAAGAAATGGAGCCAGTAGATCCTAGACTAG
AGCCCTGGAAGCATCCAGGAAGTCAGCCTAGGACCCCTTGTACCAATTGCTATTGTAAAAAGTGTTGCCT
TCATTGCCAAGTTTGTTTCACAAGAAAAGGCTTAAGCATCTCCTATGGCAGGAAGAAGCGGAGACAGCGA
CGAAGAGCTCCTCAAGACAGTCAGACTCATCAAGTTTCTCTACCAAAGCAGTAAGTAGTACATGTGATGT
TATCTTTACAAATAGCAGCAATAGTAGCATTAGTAGTAGCAGCAATAATAGTAATAGTTGTGTGGACCAT
AGTAGTCATAGAATATAGGAAATTATTAAGACAAAGAAAAATAAACAGGTTAATTGATAGACTAACAGAA
AGAGCAGAAGACAGTGGCAATGAAAGTGAAGGAGACCAGGAAGAATTATCAGCGCTTGTGGAGAGGGGGC
ACCTTGCTCCTTGGGATGTTAATGATCAGTAGTGTTGCAGGAAACTTGTGGGTCACAGTCTATTATGGGG
TACCTGTGTGGAAAGAAGCAACTACCACTCTATTTTGTGCATCAGATGCTAAAGCTTATGATACAGAGGT
ACATAATGTTTGGGCCACACATGCCTGTGTACCCACAGACCCCAACCCACAAGAAGTAGTAATGGGAAAT
GTGACAGAAAATTTTAACATGTGGAAAAATGACATGGTAGAACAGATGCAGGAAGATATAATCAGTTTAT
GGGATCAAAGCCTAAAGCCATGTGTAAAATTAACCCCACTCTGTGTTACTTTAAAATGCACTGATTATAA
TAATGCCACTAACAGTAGTTGGGGAAGGATGGAGAAAGGAGAAATACAAAACTGCTCTTTCAAGGTCACC
ACAAACATAAGAGATAAGGTACAGAAAGAATCTGCACTTTTTTATAAAACTGATGTAGTACCAATAGATA
ATAATAAGACTAGTAATAGGGATAATACTACCAGCTATATGTTGATACATTGTAATAGATCTGTCATTAC
ACAAGCCTGTCCAAAGGTATCCTTTGAGCCAATTCCCATACATTATTGTGCCCCAGCTGGTTTTGCGATT
TTAAAGTGTAATGATAAAAAGTTCAATGGAAAAGGACCATGTAAAAATGTCAGCACAGTACAGTGTACAC
ATGGAATTAGGCCAGTAGTGTCAACTCAACTGCTGTTAAATGGTAGTCTAGCAGAAAAAGAAGTAGTAAT
TAGATCTGACAATTTCACAGATAATACTAAAACCATAATAGTACATCTGAACGAATCTGTAGAAATTAAT
TGTACAAGACCCAACAACAATACAAGAAAAGGTATACATATAGGACCAGGGAGAGCAGTTTATACGACAG
GAAGAATAGTAGGAGATATAAGACTAGCACATTGTAACATTAGTAGAGCAAGATGGAATAAAACTCTAAA
CCAAATATTTAGAAAATTAAGAGAAATTAGACAATTTGAAAATAAAACAATAGTCTTTAATCGATCCTCA
GGAGGAGACCCAGAAATTGTAATGCACAGCTTTAATTGTGGAGGGGAATTTTTCTACTGTAATTCAACAA
AACTGTTTAATAGTACTTGGAATAATACTAGTACTTGGAATGATAATGGAAATGACACTATCATACTGCC
ATGTAGAATAAAACAAATTATAAACATGTGGCAGGAAGTAGGAAAAGCAATGTATGCCCCTCCCATTGGA
GGACTAATTAGATGTTCATCAAATATTACAGGGCTGATATTAACAAGAGATGGTGGTAATGATAACAGTA
GTACCACCGAGATCTTCAGACCTGGAGGGGGAAATATGAGGGACAATTGGAGAAATGAATTATATAAATA
TAAAGTAGTAAAAATTGAACCATTAGGAGTAGCACCCACCAAGGCAAAGAGAAGAGTGGTGCAGAGAGAA
AAAAGAGCGGTGGGAATGCTAGGAGCTATGTTCCTTGGGTTCTTGGGAGCAGCAGGAAGCACTATGGGCG
CACGGTCACTGACGCTGACGGTACAGGCCAGACAATTATTGTCTGGTATAGTGCAACAGCAAAACAATTT
GCTGAGAGCTATTGAGGCGCAACAACATCTGTTGCAACTCACAGTCTGGGGCATCAAACAGCTCCAGGCA
AGAGTCCTGGCTGTGGAAAGATACCTAAGGGATCAACAGCTCCTAGGGATTTGGGGTTGCTCTGGAAAAC
TCATCTGCACCACTACTGTGCCTTGGAATGCTAGTTGGAGTAATAAAACCCTGGATCAGATTTGGAATAA
CATGACCTGGATGGAGTGGGAAAGAGAAATTGACAATTACACAAGCTTAATATATACCTTAATTGAACAA
TCGCAAAACCAACAAGAAAAGAATGAACAAGAATTATTGGAATTGGATAAGTGGGCAAGTTTGTGGAGTT
GGTATGACATATCAAATTGGCTGTGGTATATAAAAATATTCATAATGATAGTAGGAGGCTTGATAGGTTT
AAGAATAGTTTTTGCTGTGCTTTCTATAGTGAATAGAGTTAGGCAGGGATACTCACCATTGTCGTTTCAG
ACCCTCCTCCCAGCAACGAGGGGACCCCGACAGCCCGAAGAAATCGAAGAAGAAGGTGGAGAGAGAGACA
GAGGCAGATCCGTTCGATTAGTGAGCGGATTCTTAGCACTTTTCTGGGACGACCTGCGGAGCCTGTGCCT
CTTCAGCTACCGCCGCTTGAGAGACTTACTCTTGATTGTAGCGAAGATTGTGGAAACTCTGGGACGCAGG
GGGTGGGAAGTCCTCAAGTATTGGTGGAATCTCCTGCAGTATTGGAGCCAGGAACTAAAGAATAGTGCTG
TCAGCTTGTTCAATACTATAGCTATAGCAGTAGCTGAGGGAACAGATAGGGTTATAGAAGTAGTACAAAG
AGCTTGTAGAGCAATTCTCCACATACCTAGAAGAGTGAGACAGGGCTTGGAAAGGGCCTTGCTATAAAAT
GGGTGGCAAGTGGTCAAAATGTAGTGGATGGCCTACTGTAAGGGAAAGAATGAAACAAGCTGAGCCTGAG
CCAGCAGCAGATGGGGTGGGAGCAGCATCTCGAGACCTGAAAAAACATGGAGCAATCACAAGTAGCAATA
CAGCAACTAATAACGCTGCTTGTGCCTGGCTAGAAGCACAAGAGGAAGAGGAAGAGGGTTTTCCAGTCAG
ACCACAGGTACCTTTAAGACCAATGACTTACAAGGGAGCTTTAGATCTTAGCCACTTTTTAAAAGAAAAG
GGGGGACTGGAAGGGTTAATTTACTCCCCAAAAAGACAAGAGATCCTTGATCTGTGGGTCTACCACACAC
AAGGCTACTTCCCTGATTGGCAGAACTACACACCAGGGCCAGGGGTCAGATATCCACTGACCTTTGGATG
GTGCTTCAAGTTAGTACCAGTTGAACCAGATGAAGAAGAGAACAGCAGCCTGTTACACCCTGCGAGCCTG
CATGGGACAGAGGACACGGAGAGAGAAGTGTTAAAGTGGAAGTTTGACAGCCATCTAGCATTTCATCACA
AGGCCCGAGAGCTGCATCCGGAGTACTACAAAGACTGCTGACACCGAGTTTTCTACAAGGGACTTTCCGC
TGGGGACTTTCCAGGGAGGCGTGACCTGGGCGGGACTGGGGAGTGGCTGGGGAGTGGCGAGCCCTCAGAT
GCTGCATATAAGCAGCCGCTTTTTGCCTGTACTGGCTCTCTCTGGTTAGACCAGATCTGAGCCTGGGAGC
TCTCTGGCTAGCTAGGGAACCCACTGCTTAAGCCTCAATAAAGCTT
Click to Show/Hide
|